St.Jude Medical Silzone

Long-Term Clinical Outcomes of Silzone Era St. Jude …

https://pubmed.ncbi.nlm.nih.gov/26182622/

Methods: Using Medicare-linked records from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (1993-2004), the clinical outcomes were evaluated through …

Silzone-coated St. Jude Medical valves: six-year …

https://pubmed.ncbi.nlm.nih.gov/17315381/

Background and aim of the study: The Silzone-coated St. Jude Medical valve was developed to reduce prosthetic valve endocarditis, but in the Artificial Valve Endocarditis …

Time-related risk of the St. Jude Silzone heart valve

https://academic.oup.com/ejcts/article/30/1/20/492361

The St. Jude "Silzone" valve: midterm results in …

https://pubmed.ncbi.nlm.nih.gov/11565654/

Background: The Silzone-coated St. Jude Medical valve (SJM "Silzone" valve), developed to reduce prosthetic valve endocarditis (PVE), was recalled by SJM due to a higher rate …

Time-related risk of the St. Jude Silzone heart valve

https://pubmed.ncbi.nlm.nih.gov/16730188/

Abstract. Objective: The St. Jude Medical Silzone heart valve had a silver-impregnated sewing ring designed to reduce the incidence of prosthetic valve endocarditis. …

(PDF) Silzone-coated St. Jude Medical valves: Six-year …

https://www.researchgate.net/publication/6491300_Silzone-coated_St_Jude_Medical_valves_Six-year_experience_in_46_patients

The Silzone-coated St. Jude Medical valve was developed to reduce prosthetic valve endocarditis, but in the Artificial Valve Endocarditis Trial (AVERT) was recalled following reports of major...

(PDF) Silzone-coated St. Jude Medical valves: six-year …

https://www.academia.edu/63368544/Silzone_coated_St_Jude_Medical_valves_six_year_experience_in_46_patients

The Silzone-coated St. Jude Medical valve was developed to reduce prosthetic valve endocarditis, but in the Artificial Valve Endocarditis Trial (AVERT) was recalled following …

Riata Defibrillation Leads Communications | Abbott

https://www.cardiovascular.abbott/us/en/hcp/product-advisories/riata.html

St. Jude Medical has a strong history of product safety and reliability, and we remain dedicated to developing technology and products that save and improve the …

Seven-year results with the St Jude Medical Silzone …

https://pubmed.ncbi.nlm.nih.gov/19379975/

The linearized occurrence rate for major thromboembolism was 0.42%/patient-year for aortic valve replacement and 1.71%/patient-year for mitral valve replacement. Conclusions: …

In re St. Jude Medical, Silzone Heart Valves Products

https://casetext.com/case/in-re-st-jude-medical-16

Defendant St. Jude Medical produced the Silzone prosthetic heart valve. A test conducted by defendant showed a higher risk of paravalvular leaks at the site where …